The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...

Four years ago, dozens of companies denounced the invasion of the U.S. Capitol and pledged to withhold support from those who ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 502.93% and ...

Among the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for hawking ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

Leveraging insights from OpenAI’s ChatGPT, Finbold has curated a $1,000 stock portfolio designed to capture growth ...

Shares of Eli Lilly & Co. LLY sank 0.08% to $795.67 Tuesday, on what proved to be an all-around favorable trading session for ...

We recently compiled a list of the 10 Stocks That Will Make You Rich In 2025. In this article, we are going to take a look at ...

In his interview with Easton Jr., Dawkins discussed representing Boehringer & Lilly’s It Takes 2 health initiative, spreading ...

Eli Lilly has signed another bolt-on deal to bulk ... new medicines for people struggling with chronic pain,” said the company’s head of pain and neurodegeneration research Mark Mintun.

With millions flowing in from corporations, Trump’s inauguration is shaping up to be the most expensive in US history ...